229 related articles for article (PubMed ID: 19884343)
21. Intracellular transport of human lysosomal alpha-mannosidase and alpha-mannosidosis-related mutants.
Hansen G; Berg T; Riise Stensland HM; Heikinheimo P; Klenow H; Evjen G; Nilssen Ø; Tollersrud OK
Biochem J; 2004 Jul; 381(Pt 2):537-46. PubMed ID: 15035660
[TBL] [Abstract][Full Text] [Related]
22. The storage products in genetic and swainsonine-induced human mannosidosis.
Cenci di Bello I; Dorling P; Winchester B
Biochem J; 1983 Dec; 215(3):693-6. PubMed ID: 6419731
[TBL] [Abstract][Full Text] [Related]
23. Substrate specificities of rat kidney lysosomal and cytosolic alpha-D-mannosidases and effects of swainsonine suggest a role of the cytosolic enzyme in glycoprotein catabolism.
Tulsiani DR; Touster O
J Biol Chem; 1987 May; 262(14):6506-14. PubMed ID: 3106356
[TBL] [Abstract][Full Text] [Related]
24. Mammalian alpha-mannosidases--multiple forms but a common purpose?
Daniel PF; Winchester B; Warren CD
Glycobiology; 1994 Oct; 4(5):551-66. PubMed ID: 7881169
[TBL] [Abstract][Full Text] [Related]
25. Over-expression of human lysosomal alpha-mannosidase in mouse embryonic stem cells.
Robinson AJ; Crawley AC; Hopwood JJ
Mol Genet Metab; 2005 Jul; 85(3):203-12. PubMed ID: 15979032
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow transplantation in the treatment of alpha-mannosidosis.
Will A; Cooper A; Hatton C; Sardharwalla IB; Evans DI; Stevens RF
Arch Dis Child; 1987 Oct; 62(10):1044-9. PubMed ID: 3314721
[TBL] [Abstract][Full Text] [Related]
27. Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis.
Harmatz P; Cattaneo F; Ardigò D; Geraci S; Hennermann JB; Guffon N; Lund A; Hendriksz CJ; Borgwardt L
Mol Genet Metab; 2018 Jun; 124(2):152-160. PubMed ID: 29716835
[TBL] [Abstract][Full Text] [Related]
28. Purification of feline lysosomal alpha-mannosidase, determination of its cDNA sequence and identification of a mutation causing alpha-mannosidosis in Persian cats.
Berg T; Tollersrud OK; Walkley SU; Siegel D; Nilssen O
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):863-70. PubMed ID: 9396732
[TBL] [Abstract][Full Text] [Related]
29. alpha-Mannosidosis: functional cloning of the lysosomal alpha-mannosidase cDNA and identification of a mutation in two affected siblings.
Nilssen O; Berg T; Riise HM; Ramachandran U; Evjen G; Hansen GM; Malm D; Tranebjaerg L; Tollersrud OK
Hum Mol Genet; 1997 May; 6(5):717-26. PubMed ID: 9158146
[TBL] [Abstract][Full Text] [Related]
30. Golgi alpha-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammals.
Moremen KW
Biochim Biophys Acta; 2002 Dec; 1573(3):225-35. PubMed ID: 12417404
[TBL] [Abstract][Full Text] [Related]
31. Lysosomal alpha-D-mannosidase.
Beccari T; Stinchi S; Orlacchio A
Biosci Rep; 1999 Jun; 19(3):157-62. PubMed ID: 10513892
[TBL] [Abstract][Full Text] [Related]
32. Oligosaccharide transport: pumping waste from the ER into lysosomes.
Moore SE
Trends Cell Biol; 1999 Nov; 9(11):441-6. PubMed ID: 10511708
[TBL] [Abstract][Full Text] [Related]
33. Oral zinc therapy in the treatment of alpha-mannosidosis.
Wong LT; Vallance H; Savage A; Davidson AG; Applegarth D
Am J Med Genet; 1993 Jun; 46(4):410-4. PubMed ID: 8357013
[TBL] [Abstract][Full Text] [Related]
34. Structural characterization of novel complex oligosaccharides accumulated in the caprine beta-mannosidosis kidney. Occurrence of tetra- and pentasaccharides containing a beta-linked mannose residue at the nonreducing terminus.
Matsuura F; Jones MZ
J Biol Chem; 1985 Dec; 260(28):15239-45. PubMed ID: 4066670
[TBL] [Abstract][Full Text] [Related]
35. Beta-mannosidosis: prenatal biochemical and morphological characteristics.
Jones MZ; Rathke EJ; Cavanagh K; Hancock LW
J Inherit Metab Dis; 1984; 7(2):80-5. PubMed ID: 6434833
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological Chaperones for the Treatment of α-Mannosidosis.
Rísquez-Cuadro R; Matsumoto R; Ortega-Caballero F; Nanba E; Higaki K; García Fernández JM; Ortiz Mellet C
J Med Chem; 2019 Jun; 62(12):5832-5843. PubMed ID: 31017416
[TBL] [Abstract][Full Text] [Related]
37. The structures of asparagine-linked oligosaccharides of rat liver cathepsin L reflect the substrate specificity of lysosomal alpha-mannosidase.
Towatari T; Miyamura T; Kondo A; Kato I; Inoue M; Yano M; Kido H
Eur J Biochem; 1998 Aug; 256(1):163-9. PubMed ID: 9746360
[TBL] [Abstract][Full Text] [Related]
38. Enzyme replacement therapy for alpha-mannosidosis: 12 months follow-up of a single centre, randomised, multiple dose study.
Borgwardt L; Dali CI; Fogh J; Månsson JE; Olsen KJ; Beck HC; Nielsen KG; Nielsen LH; Olsen SO; Riise Stensland HM; Nilssen O; Wibrand F; Thuesen AM; Pearl T; Haugsted U; Saftig P; Blanz J; Jones SA; Tylki-Szymanska A; Guffon-Fouiloux N; Beck M; Lund AM
J Inherit Metab Dis; 2013 Nov; 36(6):1015-24. PubMed ID: 23494656
[TBL] [Abstract][Full Text] [Related]
39. Chronic enzyme replacement therapy ameliorates neuropathology in alpha-mannosidosis mice.
Damme M; Stroobants S; Lüdemann M; Rothaug M; Lüllmann-Rauch R; Beck HC; Ericsson A; Andersson C; Fogh J; D'Hooge R; Saftig P; Blanz J
Ann Clin Transl Neurol; 2015 Nov; 2(11):987-1001. PubMed ID: 26817023
[TBL] [Abstract][Full Text] [Related]
40. Regional central nervous system oligosaccharide storage in caprine beta-mannosidosis.
Boyer PJ; Jones MZ; Rathke EJ; Truscott NK; Lovell KL
J Neurochem; 1990 Aug; 55(2):660-4. PubMed ID: 2370553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
